Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Vendrely

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
La Revue Du Praticien|November 18, 2021
[Restatment. Anal Cancer]Véronique Vendrely
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Chemoradiation for Unresectable Pancreatic Cancer Can Improve Quality of Life and Does Not Exclude Potential ResectionFlorence Huguet, Véronique Vendrely
Bulletin Du Cancer|November 22, 2021
[Rectal Cancer: Organ preservation and neoadjuvant treatment escalation]Véronique Vendrely, Eric Rullier
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 17, 2026
White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatmentPhilippe Giraud, Véronique Vendrely, Fabrice Lorchel, et al.
The British Journal of Surgery|May 31, 2022
Organ preservation in rectal cancer: review of contemporary managementChristina Fleming, Véronique Vendrely, Eric Rullier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 19, 2024
[Practice-changing clinical trials in gastrointestinal radiation oncology]Anouchka Modesto, Audrey Keller, Rosine Guimbaud, et al.
Bulletin Du Cancer|December 16, 2025
[Recent advances in radiotherapy]Philippe Giraud, Véronique Vendrely, Olivier Chapet, et al.
Annals of Surgical Oncology|August 30, 2014
Neoadjuvant chemoradiotherapy improves histological results compared with perioperative chemotherapy in locally advanced esophageal adenocarcinomaGuillaume Luc, Véronique Vendrely, Eric Terrebonne, et al.
Lancet (London, England)|January 23, 2018
GRECCAR2 trial: details worthy of more attention - Authors' replyEric Rullier, Véronique Vendrely, Quentin Denost, et al.
Dermatology and Therapy|February 2, 2022
An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter StudyVéronique Vendrely, Ander Mayor-Ibarguren, Aline Stennevin, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
La Revue Du Praticien|November 18, 2021
[Restatment. Anal Cancer]Véronique Vendrely
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Chemoradiation for Unresectable Pancreatic Cancer Can Improve Quality of Life and Does Not Exclude Potential ResectionFlorence Huguet, Véronique Vendrely
Bulletin Du Cancer|November 22, 2021
[Rectal Cancer: Organ preservation and neoadjuvant treatment escalation]Véronique Vendrely, Eric Rullier
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 17, 2026
White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatmentPhilippe Giraud, Véronique Vendrely, Fabrice Lorchel, et al.
The British Journal of Surgery|May 31, 2022
Organ preservation in rectal cancer: review of contemporary managementChristina Fleming, Véronique Vendrely, Eric Rullier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 19, 2024
[Practice-changing clinical trials in gastrointestinal radiation oncology]Anouchka Modesto, Audrey Keller, Rosine Guimbaud, et al.
Bulletin Du Cancer|December 16, 2025
[Recent advances in radiotherapy]Philippe Giraud, Véronique Vendrely, Olivier Chapet, et al.
Annals of Surgical Oncology|August 30, 2014
Neoadjuvant chemoradiotherapy improves histological results compared with perioperative chemotherapy in locally advanced esophageal adenocarcinomaGuillaume Luc, Véronique Vendrely, Eric Terrebonne, et al.
Lancet (London, England)|January 23, 2018
GRECCAR2 trial: details worthy of more attention - Authors' replyEric Rullier, Véronique Vendrely, Quentin Denost, et al.
Dermatology and Therapy|February 2, 2022
An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter StudyVéronique Vendrely, Ander Mayor-Ibarguren, Aline Stennevin, et al.
Pageof 11